Pterin-4 alpha-carbinolamine dehydratase 1 (PCBD1) is an enzyme essential in the recycling of **tetrahydrobiopterin (BH4)**, a critical cofactor for enzymes involved in **amino acid metabolism** and **neurotransmitter synthesis**. Besides its enzymatic role, PCBD1 also acts as a **dimerization cofactor (transcriptional coactivator)** for hepatocyte nuclear factors HNF1A (and HNF1B), thereby regulating gene transcription involved in renal magnesium handling (FXYD2), glucose metabolism, and other cellular processes. Mutations in PCBD1 can cause a rare form of **tetrahydrobiopterin deficiency** leading to hyperphenylalaninemia and have been associated with **hypomagnesemia** and, less commonly, glucose intolerance or MODY diabetes. The enzyme forms homodimers or tetramers and interacts with key transcription factors and metabolic enzymes but has no currently known direct therapeutic targeting drugs.
Other names
Pterin-4 alpha-carbinolamine dehydrataseDimerization cofactor of hepatocyte nuclear factor 1-alphaDimerization cofactor of HNF1DCoHPCBDPCDPHSPhenylalanine hydroxylase-stimulating proteinPterin carbinolamine dehydratase4-alpha-hydroxy-tetrahydropterin dehydratase6-pyruvoyl-tetrahydropterin synthase/dimerization cofactor of HNF1 alphaPterin-4a-carbinolamine dehydratase (dimerization cofactor of hepatic nuclear factor 1-alpha)
02
Mechanism of action
Potential mechanisms relate to enzyme supplementation (conceptual, not in clinical use) or modulation of cofactor (tetrahydrobiopterin, BH4) recycling; indirectly, transcriptional modulation via HNF1A/B pathways.
03
Biological functions
Tetrahydrobiopterin (BH4) metabolism and recyclingCofactor for phenylalanine hydroxylase and other aromatic amino acid hydroxylasesTranscriptional coactivation (enhances dimerization/transcriptional activity of hepatocyte nuclear factor 1-alpha and 1-beta, HNF1A/B)Amino acid metabolism (phenylalanine to tyrosine conversion)Regulation of gene transcription, especially FXYD2 and PKHD1
04
Disease associations
Hyperphenylalaninemia (BH4-deficient, D)Tetrahydrobiopterin deficiencyTransient neonatal hyperphenylalaninemiaHypomagnesemiaGlucose intolerance, potential maturity-onset diabetes of the young (MODY diabetes)Pigmentation disorders (in non-human models)Cancer (overexpressed in colon cancer and melanoma lesions)
05
Safety considerations
Generally, loss-of-function mutations cause mild metabolic abnormalities; severe toxicity is not typical.Long-term complications may include hypomagnesemia and MODY diabetes.No reported concerns for direct pharmacological inhibition, as this is not a current drug target.
06
Interacting drugs
No direct therapeutic drugs targeting PCBD1 are currently listed; its function is mainly implicated in rare metabolic disorders which are treated symptomatically (e.g., phenylketonuria therapies target upstream enzymes, not PCBD1 directly)
07
Biomarkers
Elevated phenylalaninePrimapterinuria (accumulation of specific pterin metabolites)Decreased BH4 levelsPossibly hypomagnesemia for monitoring renal complications
Beyond the preview
Go deeper on Pterin-4 alpha-carbinolamine dehydratase 1 (PCBD1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Full profile access
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Full profile access
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Full profile access
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Full profile access
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Full profile access
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Full profile access
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pterin-4 alpha-carbinolamine dehydratase 1 (PCBD1).